Marcin Radziwill - Medicover Chief Foundation
| 5M0B Stock | EUR 16.02 0.28 1.72% |
Insider
Marcin Radziwill is Chief Foundation of Medicover AB
| Phone | 46 8 40 01 76 00 |
| Web | https://www.medicover.com |
Medicover Management Efficiency
The company has return on total asset (ROA) of 0.024 % which means that it generated a profit of $0.024 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0261 %, meaning that it generated $0.0261 on every $100 dollars invested by stockholders. Medicover's management efficiency ratios could be used to measure how well Medicover manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| James Kelley | The Hanover Insurance | N/A | |
| Matthew Mitchell | The Hanover Insurance | N/A | |
| Scott Grieco | The Hanover Insurance | N/A | |
| Rohit Mull | Selective Insurance Group | N/A | |
| John Henley | United Insurance Holdings | N/A | |
| Rohan Pai | Selective Insurance Group | N/A | |
| P Condron | The Hanover Insurance | 73 | |
| Joseph CFA | Selective Insurance Group | N/A | |
| Anthony Harnett | Selective Insurance Group | 50 | |
| John Bresney | Selective Insurance Group | N/A | |
| Theodore Bunting | The Hanover Insurance | 60 | |
| Martin Hughes | The Hanover Insurance | 69 | |
| Lindsay Greenfield | The Hanover Insurance | N/A | |
| Gayle Falvey | The Hanover Insurance | N/A | |
| Vincent Senia | Selective Insurance Group | 59 | |
| Sarah Medina | The Hanover Insurance | N/A | |
| John CPCU | Selective Insurance Group | 53 | |
| Denise Lowsley | The Hanover Insurance | 47 | |
| Dennis Kerrigan | The Hanover Insurance | 58 | |
| Jennifer Luisa | The Hanover Insurance | N/A | |
| Brooke Adler | United Insurance Holdings | 46 | |
Management Performance
| Return On Equity | 0.0261 | |||
| Return On Asset | 0.024 |
Medicover AB Leadership Team
Elected by the shareholders, the Medicover's board of directors comprises two types of representatives: Medicover inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medicover. The board's role is to monitor Medicover's management team and ensure that shareholders' interests are well served. Medicover's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medicover's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hanna Bjellquist, Head Relations | ||
| Jaroslaw Urbanczyk, Chief Officer | ||
| Liselotte Bergmark, Group Human Resources Director | ||
| Fredrik Rgmark, CEO Director | ||
| Joe Ryan, Chief Officer | ||
| Staffan Ternstrom, Chief Services | ||
| Jenny Brandt, General Legal Counsel | ||
| John Stubbington, Managing Director, Healthcare Services | ||
| Marcin Radziwill, Chief Foundation | ||
| Andrew VallanceOwen, Chief Officer |
Medicover Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medicover a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0261 | |||
| Return On Asset | 0.024 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 2.94 B | |||
| Shares Outstanding | 71.58 M | |||
| Shares Owned By Insiders | 12.90 % | |||
| Shares Owned By Institutions | 45.17 % | |||
| Price To Earning | 46.07 X | |||
| Price To Book | 4.45 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Medicover Stock
Medicover financial ratios help investors to determine whether Medicover Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicover with respect to the benefits of owning Medicover security.